Physician profile
Celeste Brabec
NPI 1588605281
$826.15
in general payments reported to CMS, 2019-2025
9 companies · $55.41 in 2025
The $55.41 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2021: $58.25 · 2022: $77.52 · 2023: $400 · 2024: $53.29 · 2025: $55.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $206.18 | 2019-2024 | Menopur |
| Vitrolife INC. | $187.54 | 2023 | |
| Organon LLC | $131.81 | 2021-2024 | Follistim Aq |
| Emd Serono, INC. | $125.06 | 2019-2025 | |
| Coopersurgical, INC. | $68.45 | 2023-2025 | Stripper |
| Hologic Sales and Service, LLC | $37.04 | 2019-2023 | Thinprep 2000 Processor |
| Galen US INC | $31.67 | 2019 | |
| Covidien Lp | $23.26 | 2019 | |
| Boston Scientific Corporation | $15.14 | 2025 | General - Therapies |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celeste Brabec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.